CDC Awards Emergent BioSolutions New Anthrax Vaccine Development Funds

March 25, 2015 3:25 PM

8 0

The Department of Health and Human Services has tapped Emergent BioSolutions to further develop a new anthrax vaccine under a 30-month, $31 million contract with funding and technical support from the Biomedical Advanced Research and Development Authority.

HHS said Monday the new vaccine, called NuThrax, will work to improve on the existing licensed vaccine as the agency seeks to reduce number of needed doses to deliver protection against anthrax.

Also read: U.S. Weighs ‘Zones of Stability’ As Part of Anti-Islamic State Effort

Read more

To category page